Catalan-Serra Ignacio, Sebastian Shaji
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Gastroenterology, Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
United European Gastroenterol J. 2025 Oct;13(8):1410-1417. doi: 10.1002/ueg2.70075. Epub 2025 Jul 9.
Inflammatory Bowel Disease (IBD) has become a global disease. The increasing incidence of inflammatory bowel disease across the world is challenging the traditional view of IBD as a western disease and represents a unique opportunity to gain an understanding of the disease in diverse ethnic groups and in different socio-economical and geographical environments. However, the continued growth in prevalence in developing countries in the coming years will lead to increased use of health-care resources due to IBD-related complications, costs of drugs and indirect health costs. Here we analyze the challenges and opportunities that this situation represents and suggest actions and potential solutions to improve the quality of IBD care globally.
炎症性肠病（IBD）已成为一种全球性疾病。全球范围内炎症性肠病发病率的不断上升正在挑战将IBD视为西方疾病的传统观念，并为在不同种族群体以及不同社会经济和地理环境中了解该疾病提供了独特机会。然而，未来几年发展中国家患病率的持续增长将因IBD相关并发症、药物成本和间接医疗成本导致医疗资源使用增加。在此，我们分析这种情况所带来的挑战和机遇，并提出提高全球IBD护理质量的行动和潜在解决方案。
